Connect with us

Cannabis News

U.S. Senate Committee To Hold Hearing On Benefits Of Psychedelics For Military Veterans

Published

4 months ago

on

The U.S. Senate Commission has heard “alternative therapies” for military veterans, many witnesses expected to discuss therapeutic benefits of psychedelic.

Field hearing will be excluded from Capitol, including the Commission of Veteran Senate Affairs in Montevallo, Alabama, Friday, veteran and psychedelic mental health treatment.

Witnesses are an officer for veteran issues (VA), coalition of veteran health care coalition Adam Marr, Compass pathways at Steve Levine, University of Alabama in Brian Schiefer (SCI-DI).

“This is a call for action. Veterans don’t break the system,” The marijuana moments said on Thursday Thursday. “VA makes some good things, but what they don’t do well are these new innovations and have approaches to bring them.”

Writing the testimony to be submitted to the committee “alternative therapies” said “, therefore,” therapies are being created or psychedelic, psilocybin, dmt, 5-meo-dmt, Methylon. “

“In general, these therapies of psychedelic therapies are also fast and solid symptoms offer rapid and strong improvements.

“Despite the promising results, psychedelic therapies face the regulatory research barriers” and the access said in the testimony. It also said that “difficult understanding” is why federal federations only offered “minimum” funding to support research on therapeutic benefits of substances.

Most witnesses selected hearing They have somehow been psychedelic research and defense.

For example, Ixse Wiechers, Director General of Veterans Health Administration (VHA), was among the authors of a 2024 report among the authors of research on research and implementation of psychedelic research research on VA 2024.

Levine serves as a director of patients compass, a biotechnology research company specializing in Psychodelics, who helped protect a nomination of the Psilocybin of the Food and Drug Administration (FDA).

Schiefer also promotes the therapeutic benefits of psychedelic medicine as the role of SCI-DI to spread access to alternative therapies for veterans with severe mental and physical conditions with severe mental and physical conditions.

Notable, in the situation of a member of the Audition Committee, Tommy Tuberville (R-al), who has provided support for the Canavy Industry Bank But it is not particularly proactive in the face of psychedelic reform.

The meeting of the Senate is broader in Congress carefully to the subject. On both sides of Congress, as well as key officials of the administration to deform reform.

For example, Vako’s head recently He assumed his role to promote access to psychedelic access to veterans With serious mental health conditions, it was possible to open “wider than thought that door”.

VA Secretary Doug Collins, who He has raised attention to the President Donald TrumpHe said, “We will do the right way,” Ibogaine, MDMA and PSilocybin to face the clinical trials that are being investigated.

Last month, the Secretary also confirmed “Very open” to spread access to psychedelic therapy for veterans-Massionate that people with serious mental health conditions intend to find “healing” ways and not only treat surface symptoms.

Collins pointed out that VA is actively performed through internal or private cooperation in clinical trials “actually results in different substances that are good results”, including One is investigating a supported MDMA-based therapy based on VA Bronx health care “Actually, good results.”

In that conversation, it was also Collins He showed the last clip of the army stamps in Rob O’Neill, who killed Osama bin Laden, The federal government intentionally avoided his theory, because he has prevented access to psychedelic medicine, because cures are more profitable than long-term treatments. Collins replied in response: “I will tell you right now: this secretary of veterans, myself, I want to heal people.”

In the meantime, the GOP-controlled household board approved a change attached to the defense invoice “Progress Report” is required in a Psychedelic Pilot Therapy program For active duty for military service members and veterans.

However, the Congress has been a research proposal for psychedelic research in recent sessions, last week, has blocked a change of bipartisan bipartisa (R-TX) that would provide another $ 10 million. Clinical essays in therapeutic potential of substances like ibogaine and psilocybin in the therapeutic potential of clinical support.

–
Marijuana is a moment Monitoring of hundreds of cannabis, psychedelic and drug policy invoices This year’s state legislatures and congresses. Patreon supporters At least $ 25 / monthly enter our interactive maps, graphs and listening to the listening calendar, so they do not lose development.

Learn more about us Marihuana Bill Tracker and become Assistant Patreon to get access.
–

One by one, Bipartisan Congress legislators met with VA secretary Discuss paths to access psychedelic medicine As an alternative treatment for conditions like PTSD.

After Meeting by asking for Collins In May, reps. Lou Correa (D-CA) and Jack Bergman (R-Mi) The chairs of psychedelic psychedelic psychedelic psychedelics (path) Caucus said three.

Collins, in particular, is highlighted as VA Secretariat for Sustnator, which explores the potential of Ubogaine and MDMA, providing relief of serious mental health conditions, Robert F. Kennedy Jr., HHS head, is his goal. Release plant-based medicine options within 12 months.

New Gingrich (R-GA) separated the former speaker of the US Psychedelic Ibogaine is a “amazing breakthrough” The current “patient care system” has left people with serious mental health conditions, unintentionally intended by alternative treatment options, and intends to use its impact on the problem.

One by one, he entered the change of expenditure invoices in Correa and BergmanResearch on the benefits of psychedelic treatment to treat medical conditions It usually affects military veterans.

Legislators separated the bill in April to provide $ 30 million each year Establish psychedelic by the “Centers for Excellence” at VA FacilitiesVeterans to receive an innovative treatment that contains substances such as Psilocybin, MDMA and Ibogaine.

Collins, for his part, also known in April he had “open eye” with Kennedy About the therapeutic potential of psychedelic medicine. And he said that the government is open to the idea of ​​giving boots to cover the costs of psychedelic therapy for veterans who receive external services from VA. As a congress.

Bergman also has Advanced Psychedelic Reform Opportunity to advance through TrumpThe administration argues that federal expenditure and the efforts will give the “spine” agencies to deal with complex problems.

Kennedy, for his part, also said in April Had “wonderful experience” with LSD in 15 yearsHe thought he could see the dinosaurs, as he portrayed in a comic book.

Last October, Kennedy criticized the FDA “Psychodelics Support” of the Agency and said the laundry of other issues.

In December, VA reported individually to finance $ 1.5 million to finance Learn the effectiveness of therapy assisted by MDMA for veterans PTSD and alcohol use disorder (AUD).

Last year, VA Yehuda also financed the initial examination agency “Amazing and strong results” from the first clinical test of MDMA therapy.

In January, Shereef Elnahah Bed secretary was VA (it was very gratifying) Trump said Kennedy Lead HHS protected Psychedelics reform. And he He hoped to work with him For the next administration, but that did not come out.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Become patreon guard!

(Tagstotranslate) highlighted

Related Topics:
Continue Reading

Cannabis News

US (FL): Cannabis company countersues competitor for AI-fabricated extortion

Published

3 hours ago

on

December 9, 2025

By


Leafwell Inc. filed a federal lawsuit against medical marijuana company My Florida Green, alleging that its competitor used artificial intelligence to make legal claims as part of an extortion scheme designed to harm Leafwell’s business. The lawsuit was filed in U.S. District Court…

Continue Reading

Cannabis News

Maine Officials Approve 2026 Ballot Initiative To Largely Repeal Marijuana Legalization Law For Signature Collection

Published

3 hours ago

on

December 9, 2025

By

Maine officials have given permission to prohibition activists to begin gathering signatures for a proposal A ballot initiative that would roll back the state’s voter-approved marijuana legalization law. The measure, if passed, would also overhaul the regulatory structure of the medical cannabis program by establishing product testing requirements.

The proposal — called the “Cannabis Legalization Act and Maine Medical Use of Cannabis Act” — is a revamped version of a marijuana initiative introduced in September, sponsored by a Republican state senator and a former top staffer for then-Gov. Paul LePage (R), staunch prohibitionist.

The latest proposal, a petition approved by the Secretary of State on Monday, would remove and amend multiple sections of the current state statute, which voters approved in 2016 to effectively repeal the legalization of recreational marijuana sales.

Adults over the age of 21 would remain legal to possess 2.5 ounces of cannabis under the proposal, but a section of the law allowing home cultivation would be repealed. The sale and home cultivation of medical marijuana would be legal.

Madison Carey, who was listed as a lead petitioner in the original version of the repeal initiative and remains involved in the current campaign, told Marihuana Momenti on Tuesday that “there needs to be regulation of marijuana,” arguing that her own experience recovering from opioid misuse disorder speaks to the inadequacy of the current law.

“My hope is to raise awareness of the reality of the potential dangers of not having regulation,” he said. “I think people are fed up with the constant use — the constant (retail businesses) coming up where people can legally buy marijuana.”

Of course, repealing the voter-approved law that established the adult-licensed sales system would eliminate the current regulatory infrastructure in place, which reform advocates say helps mitigate public health and safety risks associated with the illegal market.

Rep. David Boyer (R), who led the fight to get a cannabis legalization initiative on Maine’s ballot in 2016 when he was a staff member at the Marihuana Policy Project, said voters should refuse to sign petitions for the new initiative.

“Don’t stop Maine’s progress, don’t stop signing this unfair repeal initiative,” he told Marijuana Moment on Tuesday. “Repealing the legalization of cannabis would shut down an industry larger than lobsters, potatoes and blueberries combined, costing our state jobs, revenue and economic growth.”

According to the new measure, the director of the Office of Cannabis Policy will “advance policies that promote the health and welfare of the people of the state and protect their health and safety, emphasizing the health and welfare of minors as a priority consideration in the performance of all duties.”

They should also “ensure that eligible patients maintain access to high-quality, effective, and affordable medical cannabis under this Act.”

Under the proposal, the Department of Administrative and Financial Services would create a testing program for cannabis products that would require dispensaries and dispensaries to send those products to a licensed facility for safety evaluation before dispensing them to qualified patients.

The testing facility “should ensure that cannabis or cannabis products do not exceed acceptable levels of contamination for any contaminants that are harmful to health and require testing and ensure proper labeling.”

“The department shall adopt rules establishing a testing program under this section, rules identifying the types of pollutants harmful to health, which must be tested for cannabis and cannabis products under this chapter, and rules regarding the maximum level of contamination for each pollutant,” the vote said. the initiative the text says

Additionally, regulators should administer a system to track cannabis plants from seed to the point of retail sale or disposal. That system “should be able to track cannabis plants in groups during the cultivation phase and when passing from the cultivation phase to another registrar”.

Entrepreneurs must submit at least 67,682 valid voter signatures by February 2, 2026 to be eligible for next year’s ballot. If approved by voters, the initiative would take effect on January 1, 2028.

—
It’s Marijuana Moment tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.

Learn more about our marijuana bill tracking and become a Patreon supporter to gain access
—

Maine lawmakers passed a bill in June legalize possession of an ounce of psilocybin Adults over 21 years of age.

After a different effort in the state last year legalize psilocybin and allow adults to access the psychedelic in state-licensed facilities. But lawmakers watered down that bill—instead, they changed it to create a committee to study further reforms—and in the end it was not approved.

Meanwhile, Maine legislators in February A top marijuana official voted to investigate possible conflicts of interest.

And last year, the law that allowed people came into force now apply for legal marijuana crime records to be sealed.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

By concentrating our portfolio, we create room for innovation and growth

Published

1 day ago

on

December 8, 2025

By






Viscon transfers the range fork product portfolio to Flier






Viscon Plant Technology will transfer its spacer fork product portfolio (including spacer forks and fixed forks) to Flier Systems effective January 1, 2026.

“The furrows are a proven solution for spacing within the sector. By transferring this portfolio to Flier Systems, the technology will remain available to both existing and new customers, with continued quality and support. Flier Systems will take over development, sales and technical service, while Viscon Plant Technology focuses on its core activities,” the team says.

© Viscon

“The transfer of the fields is a deliberate strategic step to strengthen our focus on automation solutions for plant growers and young breeders. In addition to concentrating our portfolio on technologies such as tissue culture automation, phenotypic sorting and somatic embryogenesis automation, we create room for further innovation and growth. We are pleased to have found a reliable and dedicated partner in Flier Systems,” said Nigela, who will continue the same product portfolio. Viscon Plant Technology.

“Acquiring spacer forks fits perfectly into our strategy to automate the entire production process for professional plant growers. Having just introduced the upgraded SPH transplanter/sorter, we have already taken an important step in the automation of potted plants. Acquiring spacer forks is a logical addition as it allows us to offer a complete and integrated package. Viscon,” said Ad Kranendonk, Flier Systems.



Publication date:













Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media